Astrana Health Inc (ASTH)vsUniversal Health Services Inc (UHS)
ASTH
Astrana Health Inc
$24.48
+1.92%
HEALTHCARE · Cap: $1.36B
UHS
Universal Health Services Inc
$186.72
+0.43%
HEALTHCARE · Cap: $11.41B
Smart Verdict
WallStSmart Research — data-driven comparison
Universal Health Services Inc generates 446% more annual revenue ($17.36B vs $3.18B). ASTH leads profitability with a 71.0% profit margin vs 8.6%. UHS trades at a lower P/E of 8.1x. UHS earns a higher WallStSmart Score of 76/100 (B+).
ASTH
Hold46
out of 100
Grade: D+
UHS
Strong Buy76
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-508.0%
Fair Value
$3.13
Current Price
$24.48
$21.35 premium
Margin of Safety
+78.6%
Fair Value
$1081.08
Current Price
$186.72
$894.36 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 71 of every $100 in revenue as profit
Revenue surging 42.9% year-over-year
Reasonable price relative to book value
Attractively priced relative to earnings
Every $100 of equity generates 21 in profit
Reasonable price relative to book value
Earnings expanding 42.7% YoY
Areas to Watch
Smaller company, higher risk/reward
ROE of 4.5% — below average capital efficiency
Operating margin of 1.9%
Premium valuation, high expectations priced in
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : ASTH
The strongest argument for ASTH centers on Profit Margin, Revenue Growth, Price/Book. Profitability is solid with margins at 71.0% and operating margin at 1.9%. Revenue growth of 42.9% demonstrates continued momentum.
Bull Case : UHS
The strongest argument for UHS centers on P/E Ratio, Return on Equity, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : ASTH
The primary concerns for ASTH are Market Cap, Return on Equity, Operating Margin. A P/E of 53.2x leaves little room for execution misses.
Bear Case : UHS
No major red flags identified for UHS, but monitor valuation.
Key Dynamics to Monitor
ASTH profiles as a growth stock while UHS is a value play — different risk/reward profiles.
UHS carries more volatility with a beta of 1.26 — expect wider price swings.
ASTH is growing revenue faster at 42.9% — sustainability is the question.
UHS generates stronger free cash flow (293M), providing more financial flexibility.
Bottom Line
UHS scores higher overall (76/100 vs 46/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Astrana Health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. The company is headquartered in Alhambra, California.
Universal Health Services Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?